Keywords: serono, initiates, eu-wide, raptiva, psoriasis, trial, geneva
Serono initiates EU-wide Raptiva psoriasis trial
Article | 31 July 2006
Geneva, Switzerland-based biotechnology firm Serono has initiated the CLEAREST clinical evlauation program, the first large-scale pharmaco-epidemiological study in psoriasis in ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
